Bibliography
- Evans WE , McLeodHL: Pharmacogenomics-drug disposition, drug targets, and side effects.N. Engl. J. Med.348, 538–549 (2003).
- Lee W , LockhartAC, KimRB, Rothenberg ML: Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development. Oncologist10, 104–111 (2005).
- Weinshilboum R , WangL: Pharmacogenomics: bench to bedside.Nature Rev. Drug. Discov.3, 739–748 (2004).
- Evans WE , RellingMV: Moving towards individualized medicine with pharmacogenomics.Nature429, 464–468 (2004).
- Meyer UA : Pharmacogenetics – five decades of therapeutic lessons from genetic diversity.Nature Rev. Genet.5, 669–676 (2004).
- Ingelman-Sundberg M : Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.Trends Pharmacol. Sci.4, 193–200 (2004).
- Kirchheiner J , BrosenK, DahlML et al.: CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.Acta Psychiatr. Scand.104, 173–192 (2001).
- Marshall E : Preventing toxicity with a gene test.Science302, 588–590 (2003).
- Jimenez-Sanchez G , ChildsB, ValleD: Human disease genes.Nature409, 853–855 (2001).
- Licinio J , WongML: Complexity and pharmacogenomics.Pharmacogenomics J.2, 203 (2002).
- Nebert DW , Jorge-NebertL, VesellES: Pharmacogenomics and “individualized drug therapy”: high expectations and disappointing achievements.Am. J. Pharmacogenomics3, 361–370 (2003).
- Pirazzoli A , RecchiaG: Pharmacogenetics and pharmacogenomics: are they still promising?Pharmacol. Res.49, 357–361 (2004).
- McInerney JO : Bioinformatics in a post-genomics world – the need for an inclusive approach.Pharmacogenomics J.2, 207–208 (2002).
- Beadle GW , TatumEL: Genetic control of biochemical reactions in Neurospora.Proc. Natl Acad. Sci. USA27, 499–506 (1941).
- Hannon GJ : RNA interference.Nature418, 244–251 (2002).
- McManus MT , SharpPA: Gene silencing in mammals by small interfering RNAs.Nature Rev. Genet.3, 737–747 (2002).
- Hartwell LH , HopfieldJJ, LeiblerS, Murray AW: From molecular to modular cell biology. Nature 402(Suppl.), C47–C52 (1999).
- Arnone MI , DavidsonEH: The hardwiring of development: organization and function of genomic regulatory systems.Development124, 1851–1864 (1997).
- Miklos GL , RubinGM: The role of the genome project in determining gene function: insights from model organisms.Cell86, 521–529 (1996).
- Klinghoffer RA , HamiltonTG, HochR, SorianoP: An allelic series at the PDGFαR locus indicates unequal contributions of distinct signaling pathways during development.Dev. Cell2, 103–113 (2002).
- Szallasi Z : Genetic network analysis in light of massively parallel biological data acquisition.Pac. Symp. Biocomput.,5–16 (1999).
- Tautz D : A genetic uncertainty problem.Trends Genet.16, 475–477 (2000).
- Greenspan RJ : The flexible genome.Nature Rev. Genet.2, 383–387 (2001).
- Vicsek T : Complexity: the bigger picture.Nature418, 131 (2002).
- Gottesman II , GouldTD: The endophenotype concept in psychiatry: etymology and strategic intentions.Am. J. Psychiatry160, 636–645 (2003).
- Dunlap JC : Molecular bases for circadian clocks.Cell96, 271–290 (1999).
- D’haeseleer P , LiangS, SomogyiR: Genetic network inference: from co-expression clustering to reverse engineering.Bioinformatics16, 707–726 (2000).
- Molidor R ., Sturn A, Mauer M, Trajanoski Z: New trends in bioinformatics: from genome sequence to personalized medicine. Exp. Gerontol.38, 1031–1036 (2003).
- Ioannidis J : Materializing research promises: opportunities, priorities and conflicts in translational medicine.J. Transl. Med.2, 1–6 (2004).
- Rakyan VK , BlewittME, DrukerR, PreisJI, WhitelawE: Metastable epialleles in mammals.Trends Genet.18, 348–351 (2002).
- Holliday R : The inheritance of epigenetic defects.Science238, 163–170 (1987).
- Waddington C : L’epigenotype.Endeavour1, 18–20 (1942).
- Beck S , OlekA, WalterJ: From genomics to epigenomics: a loftier view of life.Nature Biotech. 17, 1144–1145 (1999).
- Petronis A : Human morbid genetics revisited: relevance of epigenetics.Trends Genet.17(3), 141–146 (2001).
- Waterland RA , JirtleRL: Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases.Nutrition20, 63–68 (2004).
- Reik W , SantosF, MitsuyaK, MorganH, DeanW: Epigenetic asymmetry in the mammalian zygote and early embryo: relationship to lineage commitment? Philos.Trans. R. Soc. Lond. B. Biol. Sci.358, 1403–1409 (2003).
- Rasnick D , DuesbergPH: How aneuploidy affects metabolic control and causes cancer.Biochem. J.340, 621–630 (1999).
- Gasser SM : Positions of potential: nuclear organization and gene expression.Cell104, 639–642 (2001).
- Wong AHC , GottesmanII, PetronisA: Phenotypic differences in genetically dentical organisms: the epigenetic perspective.Hum. Mol. Genet.14, 11–18 (2005).
- Biederman J , MickE, FaraoneSV: Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.Am. J. Psychiat.157, 816–818 (2000).
- Torgalsboen AK : Full recovery from schizophrenia: the prognostic role of premorbid adjustment, symptoms at first admission, precipitating events and gender.Psychiat. Res.88, 143–152 (1999).
- Nicholis RD , SaitohS, HorsthemkeB: Imprinting in Prader-Willi and Angelman syndromes.Trends Genet.14, 194–200 (1998).
- Waterland RA , JirtleRL: Transposable elements: targets for early nutritional effects on epigenetic gene regulation.Mol. Cell Biol.23, 5293–5300 (2003).
- Laird PW : The power and the promise of DNA methylation markers.Nature Rev. Cancer3, 253–266 (2003).
- Baylin SB , HermanJG: Promoter hypermethylation – can this change alone ever designate true tumor suppressor gene function?J. Natl Cancer Inst.2, 664–665 (2001).
- Jaenisch R , BirdA: Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals.Nature Genet.33(Suppl.), 245–254 (2003).
- Van den Veyver I: Genetic effects of methylation diets. Annu. Rev. Nutr.22, 255 (2002).
- Kaput J : Diet–disease gene interactions.Nutrition20, 26–31 (2004).
- Shi H , MaierS, NimmrichI, YanPS, CaldwellCW, OlekA, HuangTH: Oligonucleotide-based microarray for DNA methylation analysis: principles and applications.J. Cell. Biochem.88, 138–143 (2003).
- Gitan RS , ShiH, ChenCM, YanPS, Huang TH: Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res.12, 158–164 (2002).
- Tompa R , McCallumCM, DelrowJ, HenikoffJG, van Steensel B, Henikoff S: Genome-wide profiling of DNA methylation reveals transposon targets of chromomethylase3. Curr. Biol.8, 65–68 (2002).
- Lander ES , SchorkNJ: Genetic dissection of complex traits.Science265, 2037–2048 (1994).
- Kinzler KW , NilbertMC, SuLK et al.: Identification of FAP locus genes from chromosome 5q21.Science253, 661–665 (1991).
- Gaskell PC Jr, Vance JM: Alzheimer’s disease genes and genetic testing in clinical practice. JAAPA17, 25–26, 29–30, 32 (2004).
- St George-Hyslop P , HainesJ, RogaevE et al.: Genetic evidence for a novel familial Alzheimer’s disease locus on chromosome 14. Nature Genet.2, 330–334 (1992).
- Sham PC , JonesP, RussellA et al.: Age at onset, sex, and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study.Br. J. Psychiatry165, 466–473 (1994).
- Pauls DL , BaileyJN, CarterAS, AllenCR, EgelandJA: Complex segregation analyses of old order Amish families ascertained through bipolar I individuals.Am. J. Med. Genet.60, 290–297 (1995).
- Gottesman II , ShieldsJ: Schizophrenia and Genetics: A twin study vantage point. Academic Press, New York, USA (1972).
- Gottesman II , ShieldsJ: Genetic theorizing and schizophrenia.Br. J. Psychiatry122, 15–30 (1973).
- Lenox RH , GouldTD, ManjiHK: Endophenotypes in bipolar disorder.Am. J. Med. Genet.114, 391–406 (2002).
- Egan MF , GoldbergTE: Intermediate cognitive phenotypes associated with schizophrenia.Methods Mol. Med.77, 163–197 (2003).
- Greenberg DA : There is more than one way to collect data for linkage analysis. What a study of epilepsy can tell us about linkage strategy for psychiatric disease.Arch. Gen. Psychiatry49, 745–750 (1992).
- Leboyer M , BellivierF, Nosten-BertrandM, JouventR, PaulsD, MalletJ: Psychiatric genetics: search for phenotypes.Trends Neurosci.21, 102–105 (1998).
- Duffy A , GrofP: Psychiatric diagnoses in the context of genetic studies of bipolar disorder.Bipolar Disord.3, 270–275 (2001).
- Strachan T , ReadA. Genes in pedigrees. In: Human Molecular Genetics, 2nd Edition, BIOS Scientific Publishers, Oxfordshire, UK (1999).
- Hyman SE : Neuroscience, genetics, and the future of psychiatric diagnosis.Psychopathology35, 139–144 (2002).
- Hyman SE , FentonWS: Medicine. What are the right targets for psychopharmacology?Science299, 350–351 (2003).
- Cadenhead KS , BraffDL: Endophenotyping schizotypy: a prelude to genetic studies within the schizophrenia spectrum.Schizophr Res.54, 47–57 (2002).
- Einat H , KofmanO, BelmakerRH: Animal models of bipolar disorder: from a single episode to progressive cycling models. In: Contemporary Issues in Modeling Psychopharmacology. Weiner I (Ed.), Kluwer Academic Publishers, Boston, USA, 165–180 (2000).
- Crawley JN : Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests.Brain Res.835, 18–26 (1999).
- Keating MT , SanguinettiMC: Molecular and cellular mechanisms of cardiac arrhythmias.Cell104, 569–580 (2001).
- Leppert M , BurtR, HughesJP et al.: Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps.N. Engl. J. Med.322, 904–908 (1990).
- Calkins ME , IaconoWG: Eye movement dysfunction in schizophrenia: a heritable characteristic for enhancing phenotype definition.Am. J. Med. Genet.97, 72–76 (2000).
- Braff DL , GeyerMA, SwerdlowNR: Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.Psychopharmacology156, 234–258 (2001).
- Braff DL : Psychophysiological and information-processing approaches to schizophrenia. In: Neurobiology of Mental Illness. Charney DS, Nester EJ, Bunney BS (Eds), Oxford University Press, New York, USA, 258–271 (1999).
- Braff DL , GrillonC, GeyerMA: Gating and habituation of the startle reflex in schizophrenic patients.Arch. Gen. Psychiatry49, 206–215 (1992).
- Freedman R , LeonardS, GaultJM et al.: Linkage disequilibrium for schizophrenia at the chromosome 15q13–14 locus of the α7-nicotinic acetylcholine receptor subunit gene (CHRNA7).Am. J. Med. Genet.105, 20–22 (2001).
- Liew CC , DzauVJ: Molecular genetics and genomics of heart failure.Nature Rev. Genet.5, 811–825 (2004).
- Ordovas JM : The quest for cardiovascular health in the genomic area: nutrigenetics and plasma lipoproteins.Pro. Nutr. Soc.63, 145–152 (2004).
- Strichman-Almashanu LZ , LeeRS, OnyangoPO et al.: A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes.Genome Res.12, 543–554 (2002).
- Novik KL , NimmrichI, GencB et al.: Epigenomics: genome-wide study of methylation phenomena.Curr. Issues Mol. Biol.4, 111–28 (2002).
- Ernest S , ChristensenB, GilfixBM et al.: Genetic and molecular control of folate-homocysteine metabolism in mutant mice.Mamm. Genome13, 259–267 (2002).
- Gurwitz D , LunshofJE, DedoussisG et al.: Pharmacogenomics education: ISP recommendations for medical, pharmaceutical, and health schools deans of education.Pharmacogenomics J. (In press).
- Vizirianakis IS : Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine.Eur. J. Pharm. Sci.15, 243–250 (2002).
- Gurwitz D , WeizmanA, RehaviM: Education: Teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine.Trends Pharmacol. Sci.24, 122–125 (2003).
- Frueh FW , GurwitzD: From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community.Pharmacogenomics5, 571–579 (2004).
- Rothstein MA , EppsPG: Ethical and legal implications of pharmacogenomics.Nature Rev. Genet.2, 228–231 (2001).
- Moldrup C : Ethical, social and legal implications of pharmacogenomics: a critical review.Community Genet.4, 204–214 (2001).
- Kaput J , RodriguezRL: Nutritional genomics: the next frontier in the postgenomic era.Physiol. Genomics16, 166–177 (2004).
- Muller M , KerstenS: Nutrigenomics: goals and strategies.Nature Rev. Genet.4(4), 315–322 (2003).
- Evans WJ : Protein nutrition, exercise and aging.J. Am. Coll. Nutr.23(Suppl. 6), 601S–609S (2004).
- Cornish-Bowden A , CardenasML.: Systems biology may work when we learn to understand the parts in terms of the whole. Biochem. Soc. Trans.33, 516–519 (2005).
- Dreon DM , FernstromHA,Williams PT, Krauss RM: A very-low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. Am. J. Clin. Nutr.69, 411 (1999).
- Freimer N , SabattiC: The human phenome project.Nature Genet.34, 15–21 (2003).